These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8058614)

  • 1. Pharmacokinetics of levodopa and carbidopa in rats following different routes of administration.
    Bredberg E; Lennernäs H; Paalzow L
    Pharm Res; 1994 Apr; 11(4):549-55. PubMed ID: 8058614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
    Rose S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats.
    Leppert PS; Cortese M; Fix JA
    Pharm Res; 1988 Sep; 5(9):587-91. PubMed ID: 3247321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
    Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
    Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.
    Deleu D; Ebinger G; Michotte Y
    Eur J Clin Pharmacol; 1991; 41(5):453-8. PubMed ID: 1761073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.
    Othman AA; Rosebraugh M; Chatamra K; Locke C; Dutta S
    J Parkinsons Dis; 2017; 7(2):275-278. PubMed ID: 28211816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
    Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC
    Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers.
    Nyholm D; Lewander T; Gomes-Trolin C; Bäckström T; Panagiotidis G; Ehrnebo M; Nyström C; Aquilonius SM
    Clin Neuropharmacol; 2012; 35(3):111-7. PubMed ID: 22549097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease].
    Fernandez-Pajarin G; Ares-Pensado B; Sesar A; Iglesias-Canle J; Masa-Vazquez L; Castro A
    Rev Neurol; 2018 Jul; 67(1):1-5. PubMed ID: 29923594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administration.
    Diez MJ; Garcia JJ; Prieto C; Fernandez N; Sahagun A; Sierra M
    J Neurol Sci; 2008 Aug; 271(1-2):15-20. PubMed ID: 18474374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients.
    Senek M; Nyholm D; Nielsen EI
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1299-1307. PubMed ID: 29882153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients.
    Mizutani Y; Okada Y; Ogawa M; Hasegawa T; Nabeshima T
    Biol Pharm Bull; 1995 Dec; 18(12):1729-37. PubMed ID: 8787797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of gastroretentive delivery of levodopa/carbidopa in patients with Parkinson disease.
    Chen C; Cowles VE; Sweeney M; Stolyarov ID; Illarioshkin SN
    Clin Neuropharmacol; 2012; 35(2):67-72. PubMed ID: 22377973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):576-81. PubMed ID: 8133901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid improves the bioavailability of L-dopa in rabbit plasma.
    Wang LH; Hsu KY; Uang YS; Hsu FL; Yang LM; Lin SJ
    Phytother Res; 2010 Jun; 24(6):852-8. PubMed ID: 19941381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
    Nutt JG; Carter JH; Woodward W; Hammerstad JP; Gancher ST
    Mov Disord; 1993 Apr; 8(2):139-43. PubMed ID: 8474479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the bioavailability and other pharmacokinetic parameters of levodopa (with carbidopa) in rabbits.
    Fernandez N; Prieto C; Sierra M; Diez MJ; Sahagun A; Gonzalez A; Garcia JJ
    Methods Find Exp Clin Pharmacol; 2008; 30(6):451-7. PubMed ID: 18850046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.
    Chan GL; Doudet DJ; Dobko T; Hewitt KA; Schofield P; Pate BD; Ruth TJ
    Life Sci; 1995; 56(21):1759-66. PubMed ID: 7739350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.